BOTHELL, Wash.--(BUSINESS WIRE)--Acucela today announced it will present new data on ACU-4429, an investigational therapy for dry age-related macular degeneration (AMD), at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting held in Fort Lauderdale, Florida from May 3 to May 7, 2009.
